FIG. 2.
Difference in C-peptide values (fasting, maximal, and AUC) between visit 12 and baseline (visit 12 minus visit 1) for adults and children with type 1 diabetes treated with DiaPep277 or placebo. Black column, high/moderate risk genotype, placebo treated (n = 19 adults and n = 25 children); small checkered column, low risk genotype, placebo treated (n = 5 adults and n = 7 children); large checkered column, high/moderate risk genotype, DiaPep277 treated (n = 33 adults and n = 36 children); white column, low risk genotype, DiaPep277 treated (n = 13 adults and n = 8 children).